Naloxone and Focal Cerebral Ischemia

Restricted access

If the inline PDF is not rendering correctly, you can download the PDF file here.

Article Information

© AANS, except where prohibited by US copyright law.

References

  • 1.

    Avery SFCrockard HARussell RWR: Improved survival following severe cerebral ischaemia using naloxone. J Cereb Blood Flow Metab 3 (Suppl 1):S331S3321983Avery SF Crockard HA Russell RWR: Improved survival following severe cerebral ischaemia using naloxone. J Cereb Blood Flow Metab 3 (Suppl 1):S331–S332 1983

  • 2.

    Baskin DSHosobuchi Y: Naloxone reversal of ischaemic neurological deficits in man. Lancet 2:2722751981Baskin DS Hosobuchi Y: Naloxone reversal of ischaemic neurological deficits in man. Lancet 2:272–275 1981

  • 3.

    Baskin DSKieck CFHosobuchi Y: Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons. Brain Res (In press1984)Baskin DS Kieck CF Hosobuchi Y: Naloxone reversal and morphine exacerbation of neurologic deficits secondary to focal cerebral ischemia in baboons. Brain Res (In press 1984)

  • 4.

    Baskin DSKieck CFHosobuchi Y: Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effects. Life Sci 31:220122041982Baskin DS Kieck CF Hosobuchi Y: Naloxone reversal of ischemic neurologic deficits in baboons is not mediated by systemic effects. Life Sci 31:2201–2204 1982

  • 5.

    Dullien VKGiardina WJWiese J: Naloxone's effect on reversing hyperirritability in the early stages of stroke in the spontaneously hypertensive stroke-prone rat (SHR-SP). Soc Neurosci Abstr 12:2481982 (Abstract)Dullien VK Giardina WJ Wiese J: Naloxone's effect on reversing hyperirritability in the early stages of stroke in the spontaneously hypertensive stroke-prone rat (SHR-SP). Soc Neurosci Abstr 12:248 1982 (Abstract)

  • 6.

    Faden AIHallenbeck JMBrown CQ: Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone. Neurology 32:108310871982Faden AI Hallenbeck JM Brown CQ: Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone. Neurology 32:1083–1087 1982

  • 7.

    Géraud GTrémoulet MGüell Aet al: The prognostic value of CBF measurement in subarachnoid hemorrhage: use of naloxone in focal ischemia. J Cereb Blood Flow Metab 3 (Suppl 1):S31S321983Géraud G Trémoulet M Güell A et al: The prognostic value of CBF measurement in subarachnoid hemorrhage: use of naloxone in focal ischemia. J Cereb Blood Flow Metab 3 (Suppl 1):S31–S32 1983

  • 8.

    Holaday JWD'Amato RJ: Naloxone or TRH fails to improve neurologic deficits in gerbil models of “stroke.” Life Sci 31:3853921982Holaday JW D'Amato RJ: Naloxone or TRH fails to improve neurologic deficits in gerbil models of “stroke.” Life Sci 31:385–392 1982

  • 9.

    Hosobuchi YBaskin DS: Naloxone and ischemic neurologic deficits in the gerbil: is there an effect? Science 218:5941982Hosobuchi Y Baskin DS: Naloxone and ischemic neurologic deficits in the gerbil: is there an effect? Science 218:594 1982

  • 10.

    Hosobuchi YBaskin DSWoo SK: Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone. Science 215:69711982Hosobuchi Y Baskin DS Woo SK: Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone. Science 215:69–71 1982

  • 11.

    Levy DEPike CLRawlinson DG: Failure of naloxone to limit clinical or morphological brain damage in gerbils with unilateral carotid artery occlusion. Soc Neurosci Abstr 12:2481982 (Abstract)Levy DE Pike CL Rawlinson DG: Failure of naloxone to limit clinical or morphological brain damage in gerbils with unilateral carotid artery occlusion. Soc Neurosci Abstr 12:248 1982 (Abstract)

  • 12.

    Levy RFeustel PSeveringhaus Jet al: Effect of naloxone on neurologic deficit and cortical blood flow during focal cerebral ischemia in cats. Life Sci 31:220522081982Levy R Feustel P Severinghaus J et al: Effect of naloxone on neurologic deficit and cortical blood flow during focal cerebral ischemia in cats. Life Sci 31:2205–2208 1982

  • 13.

    Nehls DGGaines CCrowell RM: Effects of naloxone in the treatment of experimental stroke in awake monkeys. Stroke 14:1231983 (Abstract)Nehls DG Gaines C Crowell RM: Effects of naloxone in the treatment of experimental stroke in awake monkeys. Stroke 14:123 1983 (Abstract)

  • 14.

    Shigeno TTeasdale GMKirkham Det al: Effects of naloxone on cerebral glucose metabolism in normal rats and rats with focal cerebral ischaemia. J Cereb Blood Flow Metab 3 (Suppl 1):S528S5291983Shigeno T Teasdale GM Kirkham D et al: Effects of naloxone on cerebral glucose metabolism in normal rats and rats with focal cerebral ischaemia. J Cereb Blood Flow Metab 3 (Suppl 1):S528–S529 1983

  • 15.

    Zabramski JMSpetzler RFSelman WRet al: Naloxone improves neurologic function during, and outcome after, temporary focal cerebral ischemia. Stroke 14:1231983 (Abstract)Zabramski JM Spetzler RF Selman WR et al: Naloxone improves neurologic function during and outcome after temporary focal cerebral ischemia. Stroke 14:123 1983 (Abstract)

  • 1.

    Baskin DSHosobuchi Y: Naloxone reversal of ischemic neurological deficits in man. Lancet 2:2722751981Baskin DS Hosobuchi Y: Naloxone reversal of ischemic neurological deficits in man. Lancet 2:272–275 1981

  • 2.

    Hanson EJ JrAnderson RESundt TM Jr: Comparison of 85krypton and 133xenon cerebral blood flow measurements before, during, and following focal, incomplete ischemia in the squirrel monkey. Circ Res 36:18261975Hanson EJ Jr Anderson RE Sundt TM Jr: Comparison of 85krypton and 133xenon cerebral blood flow measurements before during and following focal incomplete ischemia in the squirrel monkey. Circ Res 36:18–26 1975

  • 3.

    Hayakawa TWaltz AG: Immediate effects of cerebral ischemia: evolution and resolution of neurological deficits after experimental occlusion of one middle cerebral artery in conscious cats. Stroke 6:3213271975Hayakawa T Waltz AG: Immediate effects of cerebral ischemia: evolution and resolution of neurological deficits after experimental occlusion of one middle cerebral artery in conscious cats. Stroke 6:321–327 1975

  • 4.

    Holaday JWD'Amato RJ: Naloxone or TRH fails to improve neurologic deficits in gerbil models of “stroke.” Life Sci 31:3853921982Holaday JW D'Amato RJ: Naloxone or TRH fails to improve neurologic deficits in gerbil models of “stroke.” Life Sci 31:385–392 1982

  • 5.

    Hosobuchi YBaskin DSWoo SK: Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone. Science 215:69711982Hosobuchi Y Baskin DS Woo SK: Reversal of induced ischemic neurologic deficit in gerbils by the opiate antagonist naloxone. Science 215:69–71 1982

  • 6.

    Hossmann KASchuier FJ: Experimental brain infarcts in cats. I. Pathophysiological observations. Stroke 11:5835921980Hossmann KA Schuier FJ: Experimental brain infarcts in cats. I. Pathophysiological observations. Stroke 11:583–592 1980

  • 7.

    Levy RFeustel PSeveringhaus Jet al: Effect of naloxone on neurologic deficit and cortical blood flow during focal cerebral ischemia in cats. Life Sci 31:220522081982Levy R Feustel P Severinghaus J et al: Effect of naloxone on neurologic deficit and cortical blood flow during focal cerebral ischemia in cats. Life Sci 31:2205–2208 1982

  • 8.

    Misra AL: Metabolism of opiates in Adler MWManara LSamanin R (eds): Factors Affecting the Action of Narcotics. New York: Raven Press1978 pp 328330Misra AL: Metabolism of opiates in Adler MW Manara L Samanin R (eds): Factors Affecting the Action of Narcotics. New York: Raven Press 1978 pp 328–330

  • 9.

    Waltz AG: Clinical relevance of models of cerebral ischemia. Stroke 10:2112131979Waltz AG: Clinical relevance of models of cerebral ischemia. Stroke 10:211–213 1979

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 24 24 1
Full Text Views 102 102 0
PDF Downloads 36 36 0
EPUB Downloads 0 0 0

PubMed


Google Scholar